To The Moon

From my perspective, the hype around OpenClaw  is partly justified because AI is finally moving beyond simple chat to actually executing tasks. If agents can automate workflows like research or scheduling, that’s a real productivity shift. Still, I’m cautious since AI trends often run ahead of real adoption. From an investment angle, I lean toward infrastructure players. Companies like NVIDIA benefit as token consumption rises because autonomous agents require far more compute. At the same time, platforms such as Alphabet and Microsoft could capture long-term value by embedding AI execution into their ecosystems. In terms of opportunities, Tencent launching WorkBuddy shows how quickly AI can scale within large ecosystems. But personally, I still prefer global leaders like NVIDIA and

From my perspective, DBS’s $DBS(D05.SI)$ recent weakness seems more like a short-term market reaction than a fundamental issue. The one-off real estate provision and margin pressure explain most of the profit drop, while OCBC’s YoY profit growth and strong non-interest income show it’s managing both revenue and margin well. Valuation-wise, DBS looks attractive with a 5.9% dividend yield and a share price below SGD 55, offering an income cushion and potential upside for long-term investors. This makes me consider adding exposure, assuming the bank weathers geopolitical and macro volatility. Still, I’d be cautious on timing. Ongoing Middle East tensions could push DBS lower before stabilizing, so I’d likely scale in rather than buy all at once.

Buckle up, investors! The memory and semiconductor sector is on fire today, with stocks popping higher right from the open and signaling a potential return to that sweet bull trend we've all been craving. 🌟 Micron (MU) and SanDisk (SNDK) are leading the charge, showcasing epic rebound momentum that's got everyone buzzing. Micron's shares jumped over 5%, while SanDisk surged a whopping 11.6% – talk about a power move in the chip world! 💥 Let's dive deep into why this is happening. Micron's HBM3e high-bandwidth memory is the star of the show, reportedly sold out through 2027. Yeah, you read that right – fully booked for years ahead! This beast is crucial for AI data centers, supercharging everything from massive cloud servers to next-gen computing. With AI workloads exploding, demand is outp

🌟🌟🌟It is March 11 2026 and the global markets are currently in a high stakes game of "Musical Chairs" where music is an air raid siren and the seats are made of solid gold bullion.  After the VIX, Wall Street's Fear Gauge screamed to a crisis peak of 31.77 just 48 hours ago, we are finally seeing the red tide recede.  But don't unbuckle your seatbelt just yet. Investing today isn't just about spreadsheets.  It is about patience and fortitude.  It is about deciding if you are a person who panics when the lights flicker or the one who already has the generator humming in the basement. The Trump "Peace Whisper": Short Term Excursion? The big green bounce we are seeing today comes courtesy of the "Peace Whisperer himself.  President Trump has taken to the airwaves to d

My stock in focus today is $Oracle(ORCL)$ after its latest earnings showed that AI demand is still significantly outpacing supply. The company reported revenue of $17.19B, up 18% year over year, while adjusted EPS of $1.79 came in ahead of expectations. What really stands out is management raising its fiscal 2027 revenue outlook to $90B, signaling strong confidence that the AI-driven cloud boom still has plenty of runway. With demand for AI training and inference continuing to surge, Oracle believes the growth momentum could extend well beyond the near term. Another interesting point is how AI is also improving Oracle’s internal efficiency. The company mention

$Invesco QQQ(QQQ)$ QQQ closed at $49.40 on March 10, 2026, essentially unchanged (+0.02%), extending the cumulative return since the February 23 Bullish zone entry at $48.20 to +2.4%. The Bullish zone remains intact and the Buy and Hold stance is maintained. Risk Level-1 (−37%) is the current classification — the framework's lowest-risk tier — indicating that the developing correction is structurally consistent with a temporary pullback within an ongoing trend rather than a structural breakdown. However, a 55% Bearish zone entry probability within 5 days and a correction trend onset confirmed today introduce meaningful near-term caution. Two trend reversal points are identified — today and approximately 7 days from now — defining a correction phase

$Silvercorp Metals Inc(SVM)$ Silvercorp Metal(SVM) Jumps +6.40%: Silver Miner Reclaims Momentum, Eyeing $14 Resistance Latest Close Data Closed at $12.31 on 2026-03-10, up +6.40% from the previous close. The stock is now just 12.1% away from its 52-week high of $14.00. Core Market Drivers Silver prices showing renewed strength and investor rotation into precious metals likely fueled the rally. As a primary silver producer, SVM is a direct beneficiary of this macro shift. The company's recent operational updates and cost management efforts are also contributing to positive sentiment. Technical Analysis Volume was 4.32M shares, with a Volume Ratio of 0.94, indicating average participation. The 6-day RSI rebounded sharply to 51.38 from oversold levels

$Palantir Technologies Inc.(PLTR)$ PLTR closed at $151.10 on March 10, 2026, declining −3.38% in a session that reflects an active correction trend within a firmly intact Bullish zone. The cumulative return since the February 23 Bullish zone entry at $130.60 stands at +15.7% — a substantial profit cushion that provides meaningful structural support for the current holding position. The Bearish zone entry probability remains at 0% within 10 days, confirming that the correction is a structurally contained pullback within the Bullish zone framework rather than a signal of zone deterioration. Risk Level is at Level-2 (−40%) — at the threshold boundary between Level-1 and Level-2 — indicating moderate trend stress that warrants monitoring but does not

$Nauticus Robotics, Inc.(KITT)$ Nauticus Robotics, Inc.(KITT) Surged +42.46%: Volatility Explosion, $1.02 Breakout Tested Latest Close Data Closed at $1.02 on 2026-03-10, up +42.46% from $0.716. Now trading ~91.8% below its 52-week high of $12.51. Core Market Drivers The stock experienced extreme volatility with a 75.35% daily range, driven by massive retail interest as evidenced by high small-order buying volume. No specific company news was reported, suggesting the move may be driven by momentum and short-term speculative flows. Technical Analysis Volume exploded to 67.68M shares (Volume Ratio: 46.17, Turnover Rate: 241.22%), confirming the breakout. The 6-day RSI rocketed to 77.03, entering overbought territory, signaling a potential short-term

$Macrogenics(MGNX)$ MacroGenics Inc.(MGNX) Rocketed +45.34%: Biotech Surge Tests 52-Week High, $3.50 Pivot in Play Latest Close Data Closed at $3.43 (Mar 10), a massive +45.34% surge, hitting the 52-week high of $3.50 intraday. Core Market Drivers The dramatic spike is likely driven by a major short squeeze, as evidenced by recent high short interest. Significant institutional buying pressure, particularly from funds like Armistice Capital (holding ~19.4% combined), is providing strong momentum. No specific news was flagged, suggesting a technically-driven breakout. Technical Analysis Volume exploded to 14.02M shares (Volume Ratio: 15.51), confirming the breakout. RSI(6) is extremely overbought at 96.84, signaling a potential near-term pullback. M

Hello everyone! Today i want to share some trading ideas with you! 1. 6820-30: $SPDR S&P 500 ETF Trust(SPY)$ (1) this is the zone that I am reloading SPY puts; (2) it is 50% retrace, also the gap-fill for last Friday's large gap-down; (3) also the downward trendline zone from the top. Anyhow, 6636 is NOT the LOW of this down leg, and it will be revisited by the end of March. Image For SG users only, Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with unlimited trading on SG, HK, and US stocks, as well as ETFs. 🎉Cash Boost Account Now Supports 35,000+ Stocks & ETFs – Greater Flexibility Now Find out more here. Complete your first Cas

$Acurx Pharmaceuticals, LLC*(ACXP)$ Acurx Pharmaceuticals, Inc.(ACXP) Soared +48.34%: Breakout Frenzy on Heavy Volume, Eyeing $3.20-$3.30 Zone Latest Close Data Closed at $2.90 (ET), up a massive 48.34% from $1.955. The stock is still significantly below its 52-week high of $21.00, representing a 86.2% discount. Core Market Drivers No specific news was cited in the provided data, but the extreme price surge (+48%) and record volume suggest a potential catalyst (e.g., positive clinical trial rumor, short squeeze, or major undisclosed development) triggered a powerful breakout from recent consolidation. Technical Analysis The move was backed by explosive volume (34.3M shares, volume ratio 22.02), indicating strong institutional or speculative intere

$Dollar General(DG)$ is scheduled to report its fiscal fourth-quarter 2025 earnings on Thursday, March 12, 2026, before the market opens. The company is entering this report with significant momentum, having outperformed the broader retail sector over the last year. However, with the stock trading near 21x forward earnings (a 5-year high), the "whisper number" and forward guidance will likely dictate the post-earnings move more than the headline beat. Q4 2025 Earnings Expectations Dollar General’s fiscal Q3 2025 earnings (reported December 4, 2025) were a pivotal "turnaround" moment for the stock. While the market had been bracing for a mediocre performance, the company delivered a massive earnings beat that triggered a 10%+ surge in share price. Q3

$Decent Holding Inc.(DXST)$ Decent Holding Inc.(DXST) Soared +50.42%: Extreme Volume Surge Clears Key Resistance, Momentum Accelerates Latest Close Data Closed at $0.3986, up a massive 50.42% from the previous day. Despite the surge, the stock remains ~84% below its 52-week high of $2.48. Core Market Drivers The extraordinary price action appears to be driven by a massive retail and institutional inflow, evidenced by the $80.5M total buy volume. The 876.56% turnover rate indicates a complete reshuffling of shares, likely fueled by speculative momentum and a potential short squeeze scenario given the high short interest in recent days. Technical Analysis The technical picture is overwhelmingly bullish in the short term. Volume exploded to 398M shar

$Longeveron Inc(LGVN)$ Longeveron Inc(LGVN) Exploded +68.27%: Biotech Rocket Ignites, Short Squeeze Targets $1.17 High Latest Close Data: Closed at $0.891 on 2026-03-10, surging +68.27% on the day. The current price is 53.6% below its 52-week high of $1.92. Core Market Drivers: The dramatic price action appears to be a classic short squeeze, fueled by extreme retail momentum. The biotech sector remains volatile, with high-risk, high-reward sentiment driving speculative capital into micro-cap names like LGVN. Technical Analysis: Explosive volume of 250M shares (569x volume ratio) confirms massive buying pressure. RSI(6) at 87.12 indicates extreme overbought conditions, warning of a potential near-term pullback. MACD shows a strong bullish crossover